3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell, Peripheral
9
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, T-Cell
6
Lymphoma
6
Sezary Syndrome
3
Mycosis Fungoides
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Hematologic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Malignant mesenchymal tumor
1
Interventions
Everolimus
16
Octreotide
6
pembrolizumab
5
lanreotide
5
Sunitinib
5
Magnetic Resonance Spectroscopy
5
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
lenvatinib
3
arginyllysine
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
pasireotide
2
lutetium Lu 177 dotatate
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Temozolomide
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroendocrine Tumors
×
romidepsin
×
Clear all
No trials found.